Skip to main content
Clinical Trials/CTRI/2022/04/041879
CTRI/2022/04/041879
Not yet recruiting
未知

Arterial Stiffness as an Independent Predictor of Doxarubicin Induced Cadiomyopahty in Cancer Patients through periscope

Dr Mehdi Ali Mirza0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Mehdi Ali Mirza
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Dr Mehdi Ali Mirza

Eligibility Criteria

Inclusion Criteria

  • 1\. All patients receiving doxorubicin chemotherapy cumulative dose less than 360 mg/m2 for the first time.
  • 2\. Patients of either gender aged between 18 to 70 years.
  • 3\. Patient able to comply with the study related procedures.

Exclusion Criteria

  • 1\. Patients with pre\-existing cardiac abnormalities
  • 2\. Patients with any limb deformities.

Outcomes

Primary Outcomes

Not specified

Similar Trials